AML1/ETO inhibits AML1/CCAAT-enhancer binding protein-α mediated activation of the CD11c promoter and represses CD11c expression in HL60 cells

Haematologica

Volumn 88, Issue 8, 2003, Pages 956-958

  Drescher, Bettina ^a   Nagel, Stefan ^a   Krauter, Jürgen ^a   Heidenreich, Olaf ^b   Ganser, Arnold ^a   Heil, Gerhard ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b NONE

Author keywords

AML; AML1 ETO; C EBP ; CD11c; Histone deacetylation

Indexed keywords

BETA2 INTEGRIN; CCAAT ENHANCER BINDING PROTEIN ALPHA; GLYCOPROTEIN P 15095; HISTONE DEACETYLASE; HYBRID PROTEIN; MESSENGER RNA; TRANSCRIPTION FACTOR;

ARTICLE; BONE MARROW CELL; CARBOXY TERMINAL SEQUENCE; CELL DIFFERENTIATION; CHROMOSOME TRANSLOCATION 21; CHROMOSOME TRANSLOCATION 8; CONTROLLED STUDY; GENE ACTIVATION; GENE EXPRESSION; GENE IDENTIFICATION; GENE REPRESSION; HUMAN; HUMAN CELL; MARKER GENE; MOLECULAR CLONING; PROMOTER REGION; PROTEIN PROTEIN INTERACTION;

ANTIGENS, CD11C; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CORE BINDING FACTOR ALPHA 2 SUBUNIT; DNA-BINDING PROTEINS; HL-60 CELLS; HUMANS; ONCOGENE PROTEINS, FUSION; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS;

EID: 0141761408     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Downing JR. The AML1-ETO chimaeric transcription factor in acute myeloid leukaemia: biology and clinical significance. Br J Haematol 1999;106:296-308.
2. Ogawa E, Inuzuka M, Maruyama M, Satake M, Naito Fujimoto M, Ito Y, et al. Molecular cloning and characterization of PEBP2 β, the heterodimeric partner of a novel Drosophila runt-related DNA binding protein PEBP2 alpha. Virology 1993;194:314-31.
3. Wang J, Hoshino T, Redner RL, Kajigaya S, Liu JM. ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex. Proc Natl Acad Sci USA 1998;95:10860-5.
4. Lutterbach B, Westendorf JJ, Linggi B, Patten A, Moniwa M, Davie JR, et al. ETO, a target of t(8;21) in acute leukemia, interacts with the N- CoR and mSin3 corepressors. Mol Cell Biol 1998;18:7176-84.
5. Zhang DE, Zhang P, Wang ND, Hetherington CJ, Darlington GJ, Tenen DG. Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein α-deficient mice. Proc Natl Acad Sci USA 1997;94:569-74.
6. Noti JD. Sp3 mediates transcriptional activation of the leukocyte integrin genes CD11C and CD11B and cooperates with c-Jun to activate CD11C. J Biol Chem 1997; 272:24038-45.
7. Lopez-Rodriguez C, Corbi AL. PU.1 negatively regulates the CD11c integrin gene promoter through recognition of the major transcriptional start site. Eur J Immunol 1997;27:1843-7.
8. Westendorf JJ, Yamamoto CM, Lenny N, Downing JR, Selsted ME, Hiebert SW. The t(8;21) fusion product, AML1-ETO, associates with C/EBP-α, inhibits C/EBP-α-dependent transcription, and blocks granulocytic differentiation. Mol Cell Biol 1998;18:322-33.
9. Pabst T, Mueller BU, Harakawa N, Schoch C, Haferlach T, Behre G, et al. AML1-ETO downregulates the granulocytic differentiation factor C/EBPα in t(8;21) myeloid leukemia. Nat Med 2001;7:444-51.
10. Krauter J, Wattjes MP, Nagel S, Heidenreich O, Krug U, Kafert S, et al. Real-time RT-PCR for the detection and quantification of AML1/MTG8 fusion transcripts in t(8;21)-positive AML patients. Br J Haematol 1999;107: 80-5.